Literature DB >> 26235933

Trimethylamine N-Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet.

Cristiane Moraes1, Denis Fouque2, Ana Claudia F Amaral3, Denise Mafra4.   

Abstract

Low-protein diet is the recommended nutritional intervention for nondialysis chronic kidney disease (CKD) patients because excess protein intake can damage kidney function and produce uremic toxins. Some of these toxins are generated from amino acids breakdown by gut microbiota as p-cresyl sulfate and indoxyl sulfate that have been clearly associated with cardiovascular mortality in CKD patients. Another uremic toxin, trimethylamine N-oxide (TMAO), a degradation product of choline and L-carnitine (which come mainly from animal protein such as red meat and eggs) is now considered as a proatherogenic metabolite. In the present review, we will highlight the relationship between TMAO, diet and cardiovascular aspects, and the potential concerns about TMAO in nondialysis CKD patients.
Copyright © 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26235933     DOI: 10.1053/j.jrn.2015.06.004

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  22 in total

1.  Fecal microbiota analysis of polycystic kidney disease patients according to renal function: A pilot study.

Authors:  Rabi Yacoub; Girish N Nadkarni; Daniel I McSkimming; Lee D Chaves; Sham Abyad; Mark A Bryniarski; Amanda M Honan; Shruthi A Thomas; Madan Gowda; John C He; Jaime Uribarri
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-12

Review 2.  Prokaryotic Organelles: Bacterial Microcompartments in E. coli and Salmonella.

Authors:  Katie L Stewart; Andrew M Stewart; Thomas A Bobik
Journal:  EcoSal Plus       Date:  2020-10

3.  A Renal Clinician's Guide to the Gut Microbiota.

Authors:  Matthew Snelson; Annabel Biruete; Catherine McFarlane; Katrina Campbell
Journal:  J Ren Nutr       Date:  2020-01-09       Impact factor: 3.655

4.  Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine.

Authors:  J David Spence; Bradley L Urquhart; Heejung Bang
Journal:  Nephrol Dial Transplant       Date:  2015-11-14       Impact factor: 5.992

Review 5.  Plant-Based Diets, the Gut Microbiota, and Trimethylamine N-Oxide Production in Chronic Kidney Disease: Therapeutic Potential and Methodological Considerations.

Authors:  Gretchen N Wiese; Annabel Biruete; Ranjani N Moorthi; Sharon M Moe; Stephen R Lindemann; Kathleen M Hill Gallant
Journal:  J Ren Nutr       Date:  2020-06-29       Impact factor: 3.655

Review 6.  Clues to the function of bacterial microcompartments from ancillary genes.

Authors:  Henning Kirst; Cheryl A Kerfeld
Journal:  Biochem Soc Trans       Date:  2021-06-30       Impact factor: 4.919

Review 7.  Gut microbiota-derived short-chain fatty acids and kidney diseases.

Authors:  Lingzhi Li; Liang Ma; Ping Fu
Journal:  Drug Des Devel Ther       Date:  2017-12-11       Impact factor: 4.162

8.  Plasma and urinary metabolomic profiles of Down syndrome correlate with alteration of mitochondrial metabolism.

Authors:  Maria Caracausi; Veronica Ghini; Chiara Locatelli; Martina Mericio; Allison Piovesan; Francesca Antonaros; Maria Chiara Pelleri; Lorenza Vitale; Rosa Anna Vacca; Federica Bedetti; Maria Chiara Mimmi; Claudio Luchinat; Paola Turano; Pierluigi Strippoli; Guido Cocchi
Journal:  Sci Rep       Date:  2018-02-14       Impact factor: 4.379

Review 9.  Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.

Authors:  Raul Fernandez-Prado; Raquel Esteras; Maria Vanessa Perez-Gomez; Carolina Gracia-Iguacel; Emilio Gonzalez-Parra; Ana B Sanz; Alberto Ortiz; Maria Dolores Sanchez-Niño
Journal:  Nutrients       Date:  2017-05-12       Impact factor: 5.717

Review 10.  Gut microbiota in renal physiology: focus on short-chain fatty acids and their receptors.

Authors:  Jennifer L Pluznick
Journal:  Kidney Int       Date:  2016-08-26       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.